合肥UPS國(guó)際快遞 新站區(qū)UPS國(guó)際快遞寄件網(wǎng)點(diǎn) 新站區(qū)USP國(guó)際快遞 新站區(qū)UPS公司地址 新站區(qū)UPS美國(guó)專(zhuān)線雙清包稅到門(mén)！

　　UPS 會(huì)捐贈(zèng)的 200 萬(wàn)美元現(xiàn)金和 100 萬(wàn)美元的 UPS 實(shí)物服務(wù)，再加上來(lái)自Gavi 匹配的200 萬(wàn)美元的匹配，總共產(chǎn)生了 500 萬(wàn)美元，用于擴(kuò)大以前的共同努力由組織。該貢獻(xiàn)將適用于 Gavi 的 2021 年至 2025 年戰(zhàn)略時(shí)期。Gavi Matching Fund 成立于 2011 年，旨在鼓勵(lì)企業(yè)投資全球免疫。

　　這一承諾延續(xù)了 UPS 會(huì)和 UPS 與 Gavi 的長(zhǎng)期合作伙伴關(guān)系，并利用了該公司在醫(yī)療保健供應(yīng)鏈管理方面的深厚知識(shí)。UPS 會(huì)與 Gavi 的企業(yè)合作伙伴關(guān)系始于 2014 年。 從那時(shí)起，UPS 提供資金和技術(shù)專(zhuān)長(zhǎng)，旨在建立可靠的冷鏈網(wǎng)絡(luò)、擴(kuò)大疫苗的一英里交付、擴(kuò)大優(yōu)先國(guó)家受過(guò)培訓(xùn)的供應(yīng)鏈管理人員庫(kù)并帶頭創(chuàng)新。

　　“強(qiáng)大而高效的供應(yīng)鏈對(duì) Gavi 的工作至關(guān)重要，”Gavi 執(zhí)行官 Seth Berkley 博士說(shuō)。“在 UPS 會(huì)的支持下，我們近年來(lái)已經(jīng)能夠極大地?cái)U(kuò)大和改善符合 Gavi 資格的國(guó)家所依賴的供應(yīng)鏈，在世界上一些偏遠(yuǎn)的地區(qū)也是如此。我們非常感謝 UPS 會(huì)，它與 Gavi 的密切合作取得了真正突破性的成就。我們很高興能夠推動(dòng)這一富有成果的關(guān)系的下一章。”

　　“作為一個(gè)以目標(biāo)為導(dǎo)向的全球組織，我們對(duì) Gavi 使命的支持可以以重要的方式推動(dòng)我們的社會(huì)——我們孩子的未來(lái)——并催化更多私營(yíng)部門(mén)的支持，”UPS 會(huì)總裁兼 UPS 執(zhí)行官愛(ài)德華多·馬丁內(nèi)斯 (Eduardo Martinez) 說(shuō)多元化、公平和包容性官員。“我們渴望為公共部門(mén)和民間社會(huì)創(chuàng)造途徑，以更好地與私營(yíng)部門(mén)聯(lián)系，創(chuàng)建更有效的系統(tǒng)，并實(shí)現(xiàn)創(chuàng)新，以改善重要的衛(wèi)生服務(wù)和疫苗等商品的提供。”

　　在烏干達(dá)和衛(wèi)生部長(zhǎng)的支持下，UPS 和 Gavi 于 2018 年 7 月在烏干達(dá)坎帕拉周邊的三個(gè)地區(qū)開(kāi)發(fā)了一個(gè)試點(diǎn)一英里疫苗遞送網(wǎng)絡(luò)，為 300 萬(wàn)人提供服務(wù)，并專(zhuān)注于提高接受疫苗接種的烏干達(dá)兒童的百分比兒童疫苗。UPS、Gavi 和 UPS 的授權(quán)服務(wù)承包商與烏干達(dá)衛(wèi)生部合作，建立了覆蓋 150 多個(gè)診所的疫苗遞送系統(tǒng)。該試點(diǎn)受到當(dāng)?shù)匦l(wèi)生網(wǎng)絡(luò)的好評(píng)，利用冷鏈實(shí)踐、帶冰箱的車(chē)輛、溫度監(jiān)測(cè)工具、庫(kù)存管理系統(tǒng)來(lái)跟蹤庫(kù)存并在疫苗缺貨之前觸發(fā)訂購(gòu)。

　　UPS 會(huì)的捐款支持戰(zhàn)略培訓(xùn)執(zhí)行計(jì)劃 (STEP) 領(lǐng)導(dǎo)力發(fā)展計(jì)劃等活動(dòng)，該計(jì)劃旨在培養(yǎng)供應(yīng)鏈管理人員提供疫苗供應(yīng)鏈端到端管理的能力。

　　UPS (NYSE:UPS) announced today that its freight forwarding operation at Changi Airport, Singapore, has received IATA CEIV Pharma Certification for pharmaceutical logistics. The certification is the first for UPS in Asia Pacific and strengthens the value proposition of UPS’s healthcare logistics offering in the region. It is a further validation of its capabilities in the safe, secure and efficient transportation of high-value pharmaceutical products.

　　IATA’s CEIV Pharma Certification is an industry certification developed by IATA, regulators and aviation industry stakeholders. It evaluates companies on a comprehensive range of criteria including management systems, facilities, e, operations and staff expertise. The certification requires companies to meet or exceed many existing pharmaceutical standards and guidelines such as IATA Temperature Control Regulations, European Union Good Distribution Practices, World Health Organisation Annex 5 Good Distribution Practices for Pharmaceutical Products and United States Pharmacopeia Standards.

　　“Pharmaceuticals are time and temperature-sensitive, re an extra amount of care throughout the transportation process. These are not typical packages, and at times life-saving deliveries as well. This certification is an affirmation of the high standards of handling and transportation that UPS’s customers in the healthcare and life sciences sector have come to rely on for their high-value shipments,” said Lim Bee Koong, Director, Healthcare Strategy, UPS Asia Pacific.

　　As a biomedical sciences hub for the Asia Pacific region, Singapore is home to eight of the top 10 pharmaceutical companies globally, manufacturing four of the top 10 drugs by global revenue2. With a third of scrapped pharmaceuticals globally attributed to logistics issues3, maintaining the integrity of the healthcare supply chain is crucial to Singapore’s biomedical manufacturing sector.

　　Enhancing its value proposition with an industry-leading set of standards like the IATA CEIV Pharma certification is part of UPS’s vision to inspire trust and empower innovation to improve patient care across the healthcare and life sciences ecosystem.